JP2003532626A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003532626A5 JP2003532626A5 JP2001517507A JP2001517507A JP2003532626A5 JP 2003532626 A5 JP2003532626 A5 JP 2003532626A5 JP 2001517507 A JP2001517507 A JP 2001517507A JP 2001517507 A JP2001517507 A JP 2001517507A JP 2003532626 A5 JP2003532626 A5 JP 2003532626A5
- Authority
- JP
- Japan
- Prior art keywords
- embedded image
- disease
- pharmaceutical composition
- composition according
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*(*)S(NC)(=O)=O Chemical compound C*(*)S(NC)(=O)=O 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37823499A | 1999-08-19 | 1999-08-19 | |
| US09/378,234 | 1999-08-19 | ||
| US09/642,557 | 2000-08-16 | ||
| US09/642,557 US7119114B1 (en) | 1999-08-19 | 2000-08-18 | Pyrazoloanthrone and derivatives thereof as JNK inhibitors and compositions and methods related thereto |
| PCT/US2000/022727 WO2001012609A1 (en) | 1999-08-19 | 2000-08-19 | Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003532626A JP2003532626A (ja) | 2003-11-05 |
| JP2003532626A5 true JP2003532626A5 (https=) | 2007-05-24 |
Family
ID=23492297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001517507A Pending JP2003532626A (ja) | 1999-08-19 | 2000-08-19 | Ｊｎｋ阻害剤としてのピラゾロアントロン及びその誘導体並びにそれらの組成物 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1218347A1 (https=) |
| JP (1) | JP2003532626A (https=) |
| KR (2) | KR20080028516A (https=) |
| CN (1) | CN1304375C (https=) |
| AU (1) | AU780306B2 (https=) |
| CA (1) | CA2383268A1 (https=) |
| HK (1) | HK1053107A1 (https=) |
| NZ (1) | NZ517578A (https=) |
| WO (1) | WO2001012609A1 (https=) |
| ZA (1) | ZA200201312B (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040072888A1 (en) * | 1999-08-19 | 2004-04-15 | Bennett Brydon L. | Methods for treating inflammatory conditions or inhibiting JNK |
| US7119114B1 (en) | 1999-08-19 | 2006-10-10 | Signal Pharmaceuticals, Llc | Pyrazoloanthrone and derivatives thereof as JNK inhibitors and compositions and methods related thereto |
| US7429599B2 (en) * | 2000-12-06 | 2008-09-30 | Signal Pharmaceuticals, Llc | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| GB0108770D0 (en) | 2001-04-06 | 2001-05-30 | Eisai London Res Lab Ltd | Inhibitors |
| CN1300116C (zh) | 2001-04-16 | 2007-02-14 | 卫材株式会社 | 1h－吲唑化合物 |
| US7018999B2 (en) | 2001-05-16 | 2006-03-28 | Cephalon, Inc. | Methods for the treatment and prevention of pain |
| JP4414219B2 (ja) | 2001-07-23 | 2010-02-10 | メルク セローノ ソシエテ アノニム | Ｃ−ｊｕｎ−ｎ−末端キナーゼ（ｊｎｋ）インヒビターとしてのアリールスルホンアミド誘導体 |
| ATE465153T1 (de) | 2002-02-28 | 2010-05-15 | Eisai R&D Man Co Ltd | Neue indazolverbindungen mit kondensiertem ring |
| WO2003075917A1 (en) | 2002-03-08 | 2003-09-18 | Signal Pharmaceuticals, Inc. | Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| WO2003082869A1 (en) | 2002-03-28 | 2003-10-09 | Eisai Co., Ltd. | Azaindoles as inhibitors of c-jun n-terminal kinases |
| DE60316542T2 (de) | 2002-03-28 | 2008-07-03 | Eisai R&D Management Co., Ltd. | 7-azaindole als inhibitoren c-jun n-terminaler kinasen zur behandlung neurodegenerativer störungen |
| CA2479520A1 (en) * | 2002-04-05 | 2003-10-16 | Birgit Jung | P38 kinase inhibitors for treating mucus hypersecretion_ |
| CN1668733A (zh) * | 2002-05-30 | 2005-09-14 | 细胞基因公司 | 利用jnk或mkk抑制剂调节细胞分化并治疗骨髓增生异常和脊髓发育不良综合症的方法 |
| US7429609B2 (en) | 2002-05-31 | 2008-09-30 | Eisai R & D Management Co., Ltd. | Pyrazole compound and medicinal composition containing the same |
| US20040087642A1 (en) * | 2002-10-24 | 2004-05-06 | Zeldis Jerome B. | Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain |
| US20040092568A1 (en) * | 2002-10-31 | 2004-05-13 | Zeldis Jerome B. | Methods for the treatment, prevention and management of macular degeneration |
| US20050019366A1 (en) * | 2002-12-31 | 2005-01-27 | Zeldis Jerome B. | Drug-coated stents and methods of use therefor |
| GB0305142D0 (en) | 2003-03-06 | 2003-04-09 | Eisai London Res Lab Ltd | Synthesis |
| US7612086B2 (en) | 2003-05-16 | 2009-11-03 | Eisai R & D Management Co. Ltd. | JNK inhibitors |
| KR20060124610A (ko) * | 2003-11-06 | 2006-12-05 | 셀진 코포레이션 | 석면-관련된 질환 또는 장애를 치료 및 관리하기 위하여ｊｎｋ 억제제를 사용하는 방법 및 이 물질을 포함하는조성물 |
| WO2005074921A1 (en) * | 2004-02-09 | 2005-08-18 | University Of Zurich | Treatment of atherosclerosis |
| MX2007001155A (es) * | 2004-07-29 | 2007-08-14 | Creabilis Therapeutics Spa | Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1. |
| US7803824B2 (en) * | 2004-10-29 | 2010-09-28 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases to treat glaucoma |
| US20060094753A1 (en) * | 2004-10-29 | 2006-05-04 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| ZA200704889B (en) * | 2004-11-23 | 2008-09-25 | Celgene Corp | JNK inhibitors for treatment of CNS injury |
| US20060223807A1 (en) | 2005-03-29 | 2006-10-05 | University Of Massachusetts Medical School, A Massachusetts Corporation | Therapeutic methods for type I diabetes |
| BRPI0613042A2 (pt) | 2005-07-15 | 2010-12-14 | Serono Lab | inibidores de jnk para o tratamento de endometriose |
| KR20080044836A (ko) | 2005-07-15 | 2008-05-21 | 라보라뚜와르 세로노 에스. 에이. | 자궁내막증 치료용 ｊｎｋ 억제제 |
| GB0516156D0 (en) | 2005-08-05 | 2005-09-14 | Eisai London Res Lab Ltd | JNK inhibitors |
| CA2633980A1 (en) | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Improved composition for collecting and preserving placental stem cells and methods of using the composition |
| KR102484810B1 (ko) | 2016-05-25 | 2023-01-05 | (주)아모레퍼시픽 | 피부 미백용 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH538527A (de) * | 1968-11-07 | 1973-06-30 | Hoechst Ag | Verfahren zur Herstellung von faserreaktiven Farbstoffen |
| DE2200127A1 (de) * | 1972-01-03 | 1973-07-12 | Basf Ag | Verfahren zur herstellung von dichlor1,1'-dianthrachinonylen und deren derivaten |
| DE2558813C2 (de) * | 1975-12-27 | 1984-10-31 | Hoechst Ag, 6230 Frankfurt | Lichtempfindliches Gemisch mit synergistischem Initiatorsystem |
| US4198518A (en) * | 1977-09-02 | 1980-04-15 | Ciba-Geigy Corporation | Process for the production of 3-substituted pyrazolanthrones |
-
2000
- 2000-08-19 KR KR1020087006016A patent/KR20080028516A/ko not_active Withdrawn
- 2000-08-19 HK HK02109283.5A patent/HK1053107A1/zh unknown
- 2000-08-19 KR KR1020027002168A patent/KR100835700B1/ko not_active Expired - Fee Related
- 2000-08-19 NZ NZ517578A patent/NZ517578A/en unknown
- 2000-08-19 WO PCT/US2000/022727 patent/WO2001012609A1/en not_active Ceased
- 2000-08-19 CN CNB008143870A patent/CN1304375C/zh not_active Expired - Fee Related
- 2000-08-19 JP JP2001517507A patent/JP2003532626A/ja active Pending
- 2000-08-19 CA CA002383268A patent/CA2383268A1/en not_active Abandoned
- 2000-08-19 EP EP00955709A patent/EP1218347A1/en not_active Withdrawn
- 2000-08-19 AU AU67863/00A patent/AU780306B2/en not_active Ceased
-
2002
- 2002-02-15 ZA ZA200201312A patent/ZA200201312B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003532626A5 (https=) | ||
| JP2020536896A5 (https=) | ||
| RU2401269C2 (ru) | Производные пирролотриазина, применимые для лечения гиперпролиферативных нарушений и заболеваний, связанных с ангиогенезом | |
| RU2409562C2 (ru) | Новые производные 2-азетидинона в качестве ингибиторов всасывания холестерина для лечения гиперлипидемических состояний | |
| JP2018519323A5 (https=) | ||
| JP2021517113A5 (https=) | ||
| CH653993A5 (de) | Zwischenprodukte, die zur herstellung von neuen 3-amino-beta-lactam-1-sulfonsaeuren und ihren salzen verwendbar sind. | |
| IS2593B (is) | Heteróarýl-tetrahýdrópíoeridýl-sambönd gagnleg til meðferðar eða fyrirbyggingar á verkjum | |
| JP2012532112A5 (https=) | ||
| JP2002534519A5 (https=) | ||
| JP2012524084A5 (https=) | ||
| ZA200400577B (en) | Azole derivatives useful as insecticide. | |
| JP2005538944A5 (https=) | ||
| JP2008509987A5 (https=) | ||
| DE618979T1 (de) | Verbesserte methode zur herstellung von bestimmten -g(b)-lactam-antibiotika. | |
| JP2005529842A5 (https=) | ||
| JP2024519993A5 (https=) | ||
| JP2003503505A5 (https=) | ||
| RU2016125459A (ru) | Способ получения хиральных 2-арилморфолинов | |
| JP2005505583A5 (https=) | ||
| JP2014530831A5 (https=) | ||
| DE2415402A1 (de) | Cephalosporansaeurederivate, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zubereitungen | |
| JP2002512236A5 (https=) | ||
| JP2004531527A5 (https=) | ||
| JP2012036221A5 (https=) |